Vivos (RDGL) Free Cash Flow Growth (5y) (2015 - 2025)
Powered by 
Analysis
Vivos (RDGL) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8.10% |
| Sep 30, 2025 | -20.04% |
| Jun 30, 2025 | -20.39% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -22.31% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | -5.28% |
| Dec 31, 2023 | 2.76% |
| Sep 30, 2023 | -25.62% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -43.47% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | 19.34% |
| Mar 31, 2022 | -6.66% |
| Dec 31, 2021 | 41.95% |
| Sep 30, 2021 | -15.52% |
| Jun 30, 2021 | 17.58% |
| Mar 31, 2021 | 18.73% |